We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A medical device alleged to melt cellulite should be removed from the market immediately because it poses a significant safety risk and was never cleared by the FDA, patient advocacy group Public Citizen says in a July 18 letter to the FDA.
Read More
Makers of hip, knee and shoulder joint implants have two years from July 1, 2012, to apply for their products to be transitioned from Class IIb to Class III devices in Australia, according to the Therapeutic Goods Administration (TGA).
Read More
Healthcare products company Covidien said today it has officially opened a new $45 million research and development facility in Shanghai, China.
Read More
The Medical College of Wisconsin has begun a clinical study of InTone, a new, FDA-approved medical device that treats female urinary incontinence.
Read More
Boston Scientific has more than 4,500 employees in Ireland but fears that the company may be planning to reduce its footprint here are misplaced, said its CEO who trumpets the “stellar” performance of its Irish operations.
Read More